Frequency of infusion-related adverse reactions after cellular therapy product infusion in pediatric population

被引：0
|
作者：
Abujoub, Rodaina [1 ]
Alneedy, Noha [1 ]
Alshammari, Huda [1 ]
Mashaqbeh, Walid [2 ]
Elbasher, Enas [3 ]
Essa, Mohammed [3 ]
Alsultan, Abdulrahman [3 ]
机构：
[1] King Abdullah Specialist Childrens Hosp, Minist Natl Guard Hlth Affairs, Nursing, Riyadh, Saudi Arabia
[2] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia
[3] King Abdullah Specialist Childrens Hosp, Minist Natl Guard Hlth Affairs, Hematol Oncol, Riyadh, Saudi Arabia
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
NO003
引用
收藏
页码：820 / 821
页数：2
相关论文
共 50 条
  • [41] Multiple drugsLack of efficacy and infusion-related reactions: case report
    [J]. Reactions Weekly, 2021, 1836 (1) : 532 - 532
  • [42] Intraoperative thymoglobulin administration reduces infusion-related adverse events.
    Kamps, MA
    Ajas, NM
    Gillingham, KJ
    Matas, AJ
    [J]. TRANSPLANTATION, 2000, 69 (08) : S288 - S288
  • [43] Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reactions in patients with inflammatory bowel disease
    Rusch, Caroline
    Wood, Marci
    Kennedy, Amanda G.
    Tompkins, Bradley J.
    Frasca, Joseph D.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (11) : 1851 - 1857
  • [44] Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
    Baraf, Herbert S. B.
    Yood, Robert A.
    Ottery, Faith D.
    Sundy, John S.
    Becker, Michael A.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (08) : 427 - 432
  • [45] Infusion-related reactions, allergic or pseudo-allergic, potentially serious
    [J]. Reactions Weekly, 2023, 1975 (1) : 7 - 7
  • [46] Infusion-related reactions with administration of avelumab: mild and manageable side effects
    Gulley, James L.
    Kelly, Karen
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S296 - S298
  • [47] RituximabHypersensitivity reaction manifesting as infusion-related reactions: 2 case reports
    [J]. Reactions Weekly, 2019, 1781 (1) : 308 - 308
  • [48] Risks and mitigation strategies to prevent etoposide infusion-related reactions in children
    Tillman, Emma M.
    Suppes, Sarah L.
    Miles, Nicholas
    Duty, Ashley M.
    Kelley, Kelsey L.
    Goldman, Jennifer L.
    [J]. PHARMACOTHERAPY, 2021, 41 (08): : 700 - 706
  • [49] Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease
    Kakiuchi, Toshihiko
    Kimura, Sakiko
    Esaki, Motohiro
    Matsuo, Muneaki
    [J]. FRONTIERS IN PEDIATRICS, 2021, 9
  • [50] Management of infusion-related reactions in patients receiving amivantamab in the CHRYSALIS study
    Park, Keunchil
    Sabari, Joshua
    Haura, Eric B.
    Shu, Catherine A.
    Spira, Alexander
    Salgia, Ravi
    Reckamp, Karen L.
    Sanborn, Rachel E.
    Govindan, Ramaswamy
    Bauml, Joshua M.
    Curtin, Joshua C.
    Xie, John
    Roshak, Amy
    Lorenzini, Patricia
    Millington, Dawn
    Thayu, Meena
    Knoblauch, Roland E.
    Cho, Byoung Chul
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S482 - S482
12345